It is possible that the cell–cell adhesion may be weak or defective at the tumor boundary, which leads to activation of Rac1 and then promotes cell migration through the ROS–Src–STAT3–vimentin signaling cascade, as proposed in this study. The gene discussed is RAC1; the disease is neoplasm.